COVID-19 Vaccines in Inherited Retinal Degenerations (IRD), Fears, Ideas and Real Interactions

References

• Lee Y-K, Huang Y-H. Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines. 2021;9(12):1404. doi:10.3390/vaccines9121404
   PubMed Web of Science ®Google Scholar
• Lundstrom K, Barh D, Uhal BD, et al. COVID-19 vaccines and thrombosis-roadblock or dead-end street? Biomolecules. 2021;11(7):1020. doi:10.3390/biom11071020
   PubMed Web of Science ®Google Scholar
• U.S. Food & Drug Administration—COVID-19 Vaccines. Available from: https://www.fda.gov/emergency-preparedness-andresponse/coronavirus-disease-2019-covid-19/covid-19-vaccines. Accessed September 21, 2021.
   Google Scholar
• Pagon RA.: Retinitis pigmentosa.Surv Ophthalmol. 1988 Nov-Dec;33(3):137-77. doi:10.1016/0039-62578890085-9
   Google Scholar
• Stephenson KAJ, Zhu J, Dockery A, et al. Keegan clinical and genetic re-evaluation of inherited retinal degeneration pedigrees following initial negative findings on panel-based next generation sequencing. Int J Mol Sci. 2022;23(2):995. doi:10.3390/ijms2302099
   PubMed Web of Science ®Google Scholar
• Mercado NB, Zahn R, Wegmann F, et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020;586(7830):583–588. doi:10.1038/s41586-020-2607-z
   PubMed Web of Science ®Google Scholar
• Aga AK, Alkhaffaf QA, Hatem WH, et al. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588–6594. doi:10.1002/jmv.27214
   PubMed Web of Science ®Google Scholar
• Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? J Eur Acad Dermatol Venereol. 2021;35(9):e543–e545. doi:10.1111/jdv.17340
   PubMed Web of Science ®Google Scholar
• Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology. 2021;12:12.
   Google Scholar
• Ravichandran S, Natarajan R. Corneal graft rejection after COVID-19 vaccination. Indian J Ophthalmol. 2021;69(7):1953–1954. doi:10.4103/ijo.IJO_1028_21
   PubMed Web of Science ®Google Scholar
• Wasser LM, Roditi E, Zadok D, Berkowitz L, Weill Y. Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea. 2021;40(8):1070–1072. doi:10.1097/ICO.0000000000002761
   PubMed Web of Science ®Google Scholar
• Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm. 2021;29(4):730–733. doi:10.1080/09273948.2021.1946567
   PubMed Web of Science ®Google Scholar
• Bøhler AD, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye. 2021;22:1–2.
   Google Scholar
• Gabka K, Groselli S, Ulbig M. Flickering scotoma after COVID vaccination: a further possible side effect of vaccination? Ophthalmologe. 2021;118(7):735–740. doi:10.1007/s00347-021-01435-z
   PubMed Web of Science ®Google Scholar
• Book BAJ, Schmidt B, Foerster AMH. Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA Ophthalmol. 2021;139(7):e212471. doi:10.1001/jamaophthalmol.2021.2471
   PubMed Web of Science ®Google Scholar
• Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136. doi:10.1016/j.ajoc.2021.101136
   PubMedGoogle Scholar
• Subramony R, Lin LC, Knight DK, Aminlari A, Belovarski I. Bilateral retinal detachments in a healthy 22-year-old female following moderna SARS-CoV-2 vaccination. J Emerg Med. 2021;16:S0736–4679.
   Google Scholar
• Renisi G, Lombardi A, Massimo S, Alessandro I, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?. Int J Infect Dis. 2021. doi:10.1016/j.ijid.2021.07.035
   PubMed Web of Science ®Google Scholar
• Forte R, Martire C, Vingolo EM, Rispoli E, De Marco G. Retinitis pigmentosa: psychological aspects [Retinite pigmentosa ed influssi psicologici]. Oculistica. 1990;116(7):595–660.
   Google Scholar
• Vingolo EM, Messano GA, Fragiotta S, Spadea L, Petti S. Research international ocular manifestations of Ebola virus disease: an ophthalmologist’s guide to prevent Infection and panic. BioMed. 2015;2015:1
   Google Scholar
• Domanico D, Fragiotta S, Cutini A, Grenga PL, Vingolo EM. Psychosis, mood and behavioral disorders in usher syndrome: review of the literature. Med Hypothesis Discov Innov Ophthalmol. 2015;4:50–55.
   PubMedGoogle Scholar
• Domanico D, Fragiotta S, Paolo Trabucco N, Marcella V, Maria E. Genetic analysis for two Italian siblings with usher syndrome and schizophrenia. Case Rep Ophthalmol Med. 2012;2012:1–6. doi:10.1155/2012/380863
   Google Scholar
• Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vis Res. 2021;16(3):490–501. doi:10.18502/jovr.v16i3.9443
   PubMed Web of Science ®Google Scholar
• Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. J Neurol. 2021;15:1–6.
   Google Scholar
• Reyes-Capo DP, Stevens SM, Cavuoto KM. Acute abducens nerve palsy following COVID-19 vaccination. J AAPOS. 2021;25(5):302–303. doi:10.1016/j.jaapos.2021.05.003
   PubMed Web of Science ®Google Scholar
• Panovska-Stavridis I, Pivkova-Veljanovska A, Trajkova S, Lazarevska M, Grozdanova A, Filipche V. A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterr J Hematol Infect Dis. 2021;13(1):e2021048. doi:10.4084/MJHID.2021.048
   PubMed Web of Science ®Google Scholar
• Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. 2021;397(10285):e11. doi:10.1016/S0140-6736(21)00872-2
   PubMed Web of Science ®Google Scholar
• Castelli GP, Pognani C, Sozzi C, Franchini M, Vivona L. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Crit Care. 2021;25(1):137. doi:10.1186/s13054-021-03572-y
   PubMed Web of Science ®Google Scholar
• Suresh P, Petchey W. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST). BMJ Case Rep. 2021;14(6):e243931. doi:10.1136/bcr-2021-243931
   PubMedGoogle Scholar
• Dias L, Soares-dos-Reis R, Meira J, et al. Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis. 2021;30(8):105906. doi:10.1016/j.jstrokecerebrovasdis.2021.105906
   PubMed Web of Science ®Google Scholar
• Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost. 2021;19(7):1771–1775. doi:10.1111/jth.15347
   PubMed Web of Science ®Google Scholar
• Santovito LS, Pinna G. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflamm Res. 2021;70(9):931–933. doi:10.1007/s00011-021-01476-9
   PubMed Web of Science ®Google Scholar